source
- HS-10504 Shows Promising Activity in EGFR C797S–Mutant NSCLC After TKI ResistancePhase 1 data show HS-10504 yields encouraging responses and manageable safety in EGFR C797S–mutant NSCLC post TKI therapy.onclive · 2mo ago↗ source
- STAT+: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricingThe pharma industry saw its reputation among patient groups inch up last year, a new survey finds, but concerns remain over access and pricing.STAT · 2mo ago↗ source
- STAT+: A new attack on AMA’s billing codesA key GOP lawmaker is broadening the party's efforts to combat health care fraud.STAT · 2mo ago↗ source